# 32 — I03 · Independent Non-Regression Review and Scoped Acceptance

**DATE:** 2026-10-19  
**REVIEWED_MAIN_SHA:** `c47a3f24d400bec55eaee6379a0f2626bfdfc85f`  
**IMPLEMENTATION/LIVE_DEPLOYED_SHA:** `9a8775018f31111ce59b11945efec962e0db73d4`  
**EVIDENCE:** [28](./28-i03-davi-semantic-discovery-implementation.md), [29](./29-i03-independent-davi-crosscheck-review.md), [31](./31-i03-k2-k3-bounded-nonregression-remediation.md), ledger §§6.269–272, code and test-file inspection.  
**VERDICT:** `ACCEPT_WITH_RESIDUAL` for I03 semantic discovery plus bounded K2/K3 remediation; stage accepted with explicit limits, pending higher-authority conflict check at any next execution.

## Findings

- **I03 K4**: DÉLIA live discovery `CAPABILITY_NOT_MATCHED` with owner eligible=95, no invented absence/ACT, 17,335ms after remediation. Independently connected DAVI owner returned generic `candidate_count=0` with `eligible_action_count=95`, and specific product discovery returned a legitimate candidate, corroborating the source contract. Direct tests did not call execute.
- **K2**: code `_recover_prior_extraction_after_invalid_index` distinguishes invalid model index from insufficient evidence; extraction follow-up with at least two owner-derived units can project deterministically, does not accept the invalid index. Executor live: 12,313ms, six bullets, no owner reinvoke. Evidential limitation `prior_turn_evidence_only` preserved.
- **K3**: code `_propose_index_identifier` catches `_StageDeadlineExceeded` and falls back to no-match clarification after successful INDEX, without falsely claiming nested READ. RED/GREEN tests cover timeout/budget scenario. Executor live: INDEX→no_match clarification, 21,784ms, ACT=0. **The live sample did not trigger the new timeout fallback**, so that branch is SYNTHETIC_PASS, not LIVE_PROVEN.
- **K1**: TÉO methodology READ grounded in 16,943ms, no material ACT, preserved.
- **Tests**: full backend and bounded holdouts PASS executor-reported; this independent GitHub review inspected code/tests but did not independently rerun them (`TEST_NOT_RUN`). Live sample n=1 per scenario, no statistical SLA or causality claims.

## Decision and roadmap

Accept I03's bounded discovery capability and repaired continuity/budget behavior with residuals; no known material functional regression in current sampled K1–K4. Do not promote `ALGORITHM_COMPLETION=PASS`, assume all MCP capabilities covered, or treat source guidance as domain fact. **Next staged work is I04 generalization provider-neutral** (DAVI/TÉO/VISTA and renamed/non-MCP/multi-owner holds) per roadmap, gated by fresh HEAD/authorities/ledger and avoiding new planner/registry. The separate helpdesk ticket-count matter at ledger §6.271 remains a distinct unresolved scope and must not be silently closed.

```text
I03_INDEPENDENT_REVIEW=ACCEPT_WITH_RESIDUAL
I03_ACCEPTED=YES_WITH_RESIDUAL
K1_LIVE=PASS_WITH_LIMITATION
K2_LIVE=PASS_WITH_LIMITATION
K3_SAFE_CLARIFICATION=PASS
K3_TIMEOUT_FALLBACK=SYNTHETIC_PASS_LIVE_NOT_EXERCISED
K4_DAVI_DISCOVERY=PASS
INDEPENDENT_TEST_REPLAY=TEST_NOT_RUN
ALGORITHM_COMPLETION=PARTIAL
C3_EXECUTED=NO
C4_AUTHORIZED=NO
C5_AUTHORIZED=NO
NEXT=I04_PROVIDER_NEUTRAL_GENERALIZATION
```
